A comprehensive view of Novartis AG. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Novartis AG Files Patent Application for Novel Eukaryotic Cells and Methods for Recombinantly Expressing a Product of Interest
Published: April 25, 2024 by Indian Patents News
US Patent Issued to Novartis on April 23 for "Methods of treating HIV-HAART induced partial lipodystrophy with FGF21 protein variant FC fusion proteins" (Massachusetts Inventors)
Published: April 24, 2024 by U.S. Fed News
Novartis is actively managing its relationships with Chinese contractors in light of the potential passage of the BIOSECURE Act in the US; the law aims to prevent US taxpayer dollars from going to 'foreign adversary biotech companies'
Published: April 23, 2024 by FiercePharma
Novartis names former Bristol Myers Squibb CEO Giovanni Caforio as board chairman starting next year; Caforio will replace Joerg Reinhardt, who plans to retire in 2025
Published: April 23, 2024 by BioPharma Dive
Novartis reports Q1 profit of US$2.69B, Q1 revenue of US$11.83B; both results topped Wall Street expecations
Published: April 23, 2024 by Associated Press

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count